Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2011 Jan 11;286(14):12627–12639. doi: 10.1074/jbc.M110.175257

Functional Roles of a C-terminal Signaling Complex of CaV1 Channels and A-kinase Anchoring Protein 15 in Brain Neurons*

Misty R Marshall 1, John Patrick Clark III 1,1, Ruth Westenbroek 1,1, Frank H Yu 1,1, Todd Scheuer 1, William A Catterall 1,2
PMCID: PMC3069463  PMID: 21224388

Abstract

Regulation of CaV1.2 channels in cardiac myocytes by the β-adrenergic pathway requires a signaling complex in which the proteolytically processed distal C-terminal domain acts as an autoinhibitor of channel activity and mediates up-regulation by the β-adrenergic receptor and PKA bound to A-kinase anchoring protein 15 (AKAP15). We examined the significance of this distal C-terminal signaling complex for CaV1.2 and CaV1.3 channels in neurons. AKAP15 co-immunoprecipitates with CaV1.2 and CaV1.3 channels. AKAP15 has overlapping localization with CaV1.2 and CaV1.3 channels in cell bodies and proximal dendrites and is closely co-localized with CaV1.2 channels in punctate clusters. The neuronal AKAP MAP2B, which also interacts with CaV1.2 and CaV1.3 channels, has complementary localization to AKAP15, suggesting different functional roles in calcium channel regulation. Studies with mice that lack the distal C-terminal domain of CaV1.2 channels (CaV1.2ΔDCT) reveal that AKAP15 interacts with neuronal CaV1.2 channels via their C terminus in vivo and is co-localized in punctate clusters of CaV1.2 channels via that interaction. CaV1.2ΔDCT neurons have reduced L-type calcium current, indicating that the distal C-terminal domain is required for normal functional expression in vivo. Deletion of the distal C-terminal domain impairs calcium-dependent signaling from CaV1.2 channels to the nucleus, as shown by reduction in phosphorylation of the cAMP response element-binding protein. Our results define AKAP signaling complexes of CaV1.2 and CaV1.3 channels in brain and reveal three previously unrecognized functional roles for the distal C terminus of neuronal CaV1.2 channels in vivo: increased functional expression, anchoring of AKAP15 and PKA, and initiation of excitation-transcription coupling.

Keywords: Calcium Channels, CREB, Cyclic AMP (cAMP), Mouse Genetics, Protein Kinase A (PKA), AKAP15, C Terminus of Calcium Channel, CaV 1 Channels, L-type Calcium Channel, Neuronal Calcium Channels

Introduction

Voltage-gated calcium channels of the CaV1 subfamily conduct L-type calcium currents that transduce cell-surface depolarization into calcium transients and initiate excitation-contraction coupling, excitation-secretion coupling, protein phosphorylation, and gene regulation (15). Calcium influx via postsynaptic CaV1 channels supports sustained phosphorylation of cAMP response element-binding protein (CREB)3 and CREB-dependent gene expression in hippocampal neurons (613).

Functional CaV1 channels are multimeric complexes composed of pore-forming α1 and associated α2δ, β, and in some cases, γ subunits (1419). These channels have an extended C terminus containing many protein interaction sites for regulation (5). In brain, CaV1 channels are composed of 70% CaV1.2 and 22% CaV1.3 with minor contributions from other CaV1 channels, as indicated by immunoprecipitation with specific antibodies (20). CaV1.2 and CaV1.3 channels are primarily localized in the soma and proximal dendrites (20, 21).

The β-adrenergic pathway activates cAMP-dependent protein kinase (PKA) and increases the activity of CaV1 channels in skeletal and cardiac myocytes and neurons (15, 22, 23). PKA-mediated regulation of CaV1.2 channels in cardiac and skeletal muscle requires a plasma membrane-targeted A-kinase anchoring protein (AKAP15) that binds directly to CaV1.1 and CaV1.2 channels via a leucine zipper (LZ) motif in the distal C-terminal region, thereby positioning PKA in close proximity to its phosphorylation targets (2427). The LZ-like sequences in the distal C-terminal domains of cardiac, skeletal muscle, and neuronal CaV1 channels are well conserved, suggesting that AKAP15 may target CaV1.2 and CaV1.3 channels in brain through a similar motif. In contrast to the results on AKAP15 in skeletal and cardiac myocytes, a previous study showed that the AKAP microtubule-associated protein 2B (MAP2B) associates with CaV1.2 channels in brain (28). In the experiments presented here, we have further defined the C-terminal signaling complex of CaV1.2 and CaV1.3 channels in vivo. We found that AKAP15 and β2ARs are components of CaV1.2 and CaV1.3 channel signaling complexes in the brain. MAP2B and AKAP15 have complementary localization suggesting that they interact with distinct subsets of CaV1 channels in neurons. Deletion of the distal C-terminal domain of CaV1.2 channels in vivo decreased L-type calcium currents, altered the localization of AKAP15, and impaired coupling of calcium channel activation to phosphorylation of CREB. These results show that AKAP15 anchors PKA to the distal C terminus of CaV1.2 and CaV1.3 channels in brain neurons in vivo and reveal three previously unrecognized functional roles for the distal C-terminal signaling complex of CaV1.2 channels in neurons in vivo: increased functional expression, anchoring of AKAP15/PKA, and initiation of excitation-transcription coupling.

MATERIALS AND METHODS

Antibodies

Rabbit polyclonal anti-CaV1.2 (anti-CNC1) and anti-CaV1.3 (anti-CND1) and chicken polyclonal anti-CaV1.2 (anti-CNC1) were generated against amino acid sequences (29) in the intracellular loop betweens domains II and III of CaV1.2 and CaV1.3 channels as described (30, 31). An antibody against the distal C terminus (anti-CH2) was generated against residues 2051–2066 in the distal C terminus of CaV1.2 channels and characterized as described (32). Anti-AKAP15 antibodies and RII-biotin protein were prepared as described (26). Rabbit-HRP secondary antibody, streptavidin-HRP secondary antibody, and control antibodies (rabbit IgG) were purchased from Zymed Laboratories Inc. (South San Francisco, CA), and anti-phospho-CREB Ser133 and anti-phospho-ERK were from Millipore (Billerica, MA).

Preparation of Mouse Brain Membrane Proteins

All preparative steps were performed at 0–4 °C using prechilled solutions. Whole brains from 10-week-old C57Bl6 mice were homogenized in buffer containing 5 mm EDTA, 1 mm dithiothreitol, 50 mm Tris-Cl (pH 7.4), 0.32 m sucrose, and protease inhibitors. Homogenates were centrifuged at 1000 × g to remove debris, and membranes were collected by ultracentrifugation at 100,000 × g for 45 min. Membranes were solubilized in homogenization buffer containing either 2% digitonin or 0.5% Triton X-100 for 30 min with mixing by rotation, and insoluble material was removed by ultracentrifugation. All extracts contained the protease inhibitors pepstatin A (1 μm), benzamidine (100 μm), leupeptin (1 μm), aprotinin (0.3 μm), phenylmethanesulfonyl fluoride (1 mm), trypsin inhibitor (20 μg/ml), PefBloc SC (1 mm), and calpain inhibitors I and II (20 μg/ml each). Proteins that nonspecifically bind to Sepharose beads were removed by mixing mouse neuronal membrane extracts with protein A-Sepharose (5 mg) by rotation for 30 min at 4 °C. The precleared lysates were incubated with either 15 μg of affinity-purified anti-CaV1.2 channel antibody, 15 μg of affinity-purified anti-CaV1.3 channel antibody, or 15 μg of control nonimmune IgG. After 2 h of mixing at 4 °C, 5 mg of protein A-Sepharose was added for an additional 1 h. Immune complexes bound to Sepharose beads were sedimented by centrifugation and washed extensively. Samples were then extracted with 40 μl of SDS sample buffer and analyzed by SDS/PAGE on 8–16% gradient gels and immunoblotting. Each immunoprecipitation experiment was repeated at least four times.

Immunoblot Analysis

After separation by SDS-PAGE using 8–16% gels, proteins were transferred and blocked by incubation with 5% skim milk powder (5 m) in 20 mm Tris-HCl, 0.15 m NaCl (pH 7.4) (TBS) for 2 h or overnight. Blots were incubated with affinity-purified antibodies in 5% skim milk powder (SM-TBS) with anti-CaV1.2 (1:150 in SM-TBS), anti-CaV1.3 (1:100 in SM-TBS), or anti-β2AR (1:50 in SM-TBS). For AKAP15 detection, immunoblots were probed with an anti-AKAP15 antibody (1:150 in SM-TBS) or the RII-biotin overlay assay (25), which detects all AKAPs. After several rinses, streptavidin-HRP was applied to visualize the AKAP interactions, and the resulting blots were developed with standard protocols. The blots were washed with TBS containing 0.05% Tween 20 (TBST) (three changes), incubated for 1 h with horseradish peroxidase-labeled donkey anti-rabbit antibody (Amersham Biosciences) or horseradish peroxidase-labeled protein-A, diluted 1:10,000 in SM-TBST, washed 5–6 times with TBST, and developed with ECL reagent.

Generation of CaV1.2ΔDCT Mice

A stop codon was inserted into the coding sequence of the Cacna1c gene encoding CaV1.2 channels at Gly-1796, where CaV1.2 channels are truncated in vivo (33). Germ line transmission of the mutated Cacna1c allele was confirmed for one of three chimeric mice, and the resulting progeny were backcrossed into C57Bl/6J for more than 10 generations to generate the CaV1.2ΔDCT animals used in this study. Wild-type and CaV1.2ΔDCT mutant animals were identified by PCR analysis of tail-tip DNA in a 24-μl reaction containing 2 μl of DNA (100 ng/μl), 0.2 μl of 25 mm dNTPs, 2.5 μl of 10× Taq buffer (Invitrogen), 0.5 μl of forward primer (FH258, CCCACTGCACATCAACAAGAC), 0.5 μl of reverse primer (FH254, GTCCTGTGTGGAAGACTCAAGGAG), 0.2 μl of Promega Taq polymerase (5 units/μl), 0.75 μl of 50 mm MgCl2, and 19.3 μl of H2O. Cycling conditions were 94 °C for 2 min, 35× (94 °C for 20 s, 62 °C for 30 s, 72 °C for 90 s), and 72 °C for 5 min followed by storage at 4 °C. The transgene produces a DNA product of 908 bp from all transgenic animals, which is further analyzed using an NcoI restriction digest to detect the NcoI restriction site in exon 44 that has been removed in CaV1.2ΔDCT mice. Wild-type mice show a DNA band of 702 bp, whereas CaV1.2ΔDCT mice show a DNA band of 908 bp. Heterozygous mice have both DNA bands.

Isolation of Hippocampal Neurons

Cultures of hippocampal neurons were prepared essentially as described previously (13). In brief, hippocampi were isolated from embryonic day 18 mice, and the CA1-CA3 region was dissected in Hanks' balanced salt solution containing 10 mm MgCl2 (HBSS+Mg2+). The dentate gyrus was removed to minimize inhibitory neurons in the cultures. The tissue was incubated in HBSS+Mg2+ containing 1 mg/ml activated papain (Worthington Biochemical, Freehold, NJ) at 37 °C for 30 min. The tissue was rinsed with HBSS+Mg2+ and dissociated to a single cell suspension by gentle passage through a 2-ml serological pipette, seeded onto 24-well plates coated with mouse laminin/poly-d-lysine, and maintained in neurobasal medium supplemented with B27 (Invitrogen). Cells were plated at 2 × 104 cells per well in 24-well tissue culture plates for immunocytochemistry or at 3 × 104 cells per plate for electrophysiology. Proliferation of non-neuronal cells was prevented by the addition of 0.08 mm fluorodeoxyuridine and 0.2 mm uridine (Sigma) from the third day in culture. Electrophysiological recordings were performed 10–16 days after plating.

Single-label Immunocytochemistry

Mice pregnant for 18 days were anesthetized and intracardially perfused with 4% paraformaldehyde. The brains of the pups were immediately removed, postfixed for 1 h, cryoprotected by sinking in 10% (w/v) and 30% (w/v) sucrose in 0.1 m sodium phosphate (pH 7.4 (PB)) at 4 °C for 72 h, and sectioned into 40-μm coronal and sagittal slices. The tissue sections were mounted on subbed slides and then processed for immunocytochemistry. The sections were rinsed in PB, fixed in 4% paraformaldehyde for 45 min, rinsed in PB for 5 min, rinsed in 0.1 m Tris buffer (pH 7.4 (TB)) for 15 min, rinsed in 0.1 m Tris-buffered saline (pH 7.4 (TBS)) for 15 min, and blocked in TBS containing 0.1% Triton X-100 and 10% normal goat serum. The sections were then incubated in anti-CaV1.2 (diluted 1:25), anti-CaV1.3 (diluted 1:25), anti-CH2 (diluted 1:15), or anti-AKAP15 (diluted 1:15) overnight at room temperature, rinsed in TBS, incubated in biotinylated goat anti-rabbit IgG (diluted 1:300, Vector Laboratories, Burlingame, CA) for 2 h at room temperature, rinsed in TBS, incubated in avidin D-fluorescein (diluted 1:300, Vector) for 2 h at room temperature, rinsed, and coverslipped using Vectashield.

Double-label Immunocytochemistry

Two-month-old C57Bl/6 mice were anesthetized and intracardially perfused with 4% paraformaldehyde in PB, and then the brains were removed, post-fixed, cryoprotected, and sectioned as described above. Free-floating slices were processed for immunocytochemistry using the method described previously (34). Tissue slices were incubated for 36 h at 4 °C with rabbit anti-CaV1.2 (1:25), rabbit anti-AKAP15 (1:25), mouse anti-MAP2B (1:200), chicken anti-CaV1.2 (1:25), chicken anti-β2AR (1:25), or rabbit anti-CaV1.3 antibodies (1:25) diluted in 1% normal goat serum and 0.1% Triton X-100 in TBS. One bound primary antibody was detected using appropriate biotinylated IgG and avidin labeled with d-fluorescein, and the second bound primary antibody was detected with Alexa 555-labeled secondary antibody. Images were viewed using either the Leica SL or Bio-Rad MRC 600 confocal microscope in the W. M. Keck Imaging Facility. Control experiments were performed to confirm the specificity of labeling by omitting the primary antibody and using peptide-blocked antibodies as described previously (30, 35). Double labeling using two rabbit polyclonal antibodies was carried out as described (36).

Electrophysiology

Whole-cell Ba2+ currents (IBa) were recorded at room temperature from 10–14-day cultured neurons for total calcium channel currents (5 mm Ba2+), non-L-type currents (in the presence of 10 μm nimodipine), and background currents (by substituting Co2+ for Ba2+). The extracellular bath solution contained 140 mm tetraethylammonium-HCl, 2 mm MgCl2, 5 mm BaCl2, 10 mm Hepes, 10 mm glucose (pH 7.4), and 0.5 μm tetrodotoxin. Patch pipettes were filled with an intracellular solution containing 115 mm cesium methanesulfonate, 10 mm MgATP, 0.5 mm CsEGTA, 0.25 mm CaCl2, 20 mm Hepes, 1 mm Tris GTP, 10 mm phosphocreatine, pH 7.21. Calcium channel currents were isolated by blocking Na+ currents with tetrodotoxin and K+ currents with tetraethylammonium and Cs+. L-type currents were further distinguished with holding potentials selected to inactivate low voltage-activated calcium currents (VH = −50 mV). To estimate the extent of current rundown, time-matched controls omitting nimodipine were recorded in parallel with the experimental cells. Currents were recorded with an Axopatch 200B amplifier (Molecular Devices, Union City, CA) and sampled at 50 kHz after filtering at 8 kHz. Data acquisition and command potentials were controlled by Pulse software (HEKA Electronik, Lambrecht, Germany), and data were stored for off-line analysis using Igor Pro (Wavemetrics, Lake Oswego, OR).

Measurement of CREB Phosphorylation

Dissociated CA1/3 hippocampal neurons from E18 wild-type and CaV1.2ΔDCT mice were maintained in culture for 8–14 days on a laminin/poly-d-lysine substrate (1:100 dilution, BD Biosciences) in Neurobasal A medium (Invitrogen) supplemented with B-27 (Invitrogen). Hippocampal neurons were stimulated by depolarization with solution containing 75 mm NaCl, 65 mm KCl, 2 mm CaCl2, 1 mm MgCl2, 25 mm Hepes, and 10 mm glucose. Sodium channels were blocked with 1 μm tetrodotoxin added the night before stimulation. P/Q- and N-type calcium currents were blocked with 1 μm ω-agatoxin IVA and 1 μm ω-conotoxin GIVA (Alomone Labs). N-Methyl-d-aspartate receptors were blocked with 100 μm d,l,-2-amino-5-phosphonovaleric acid (Tocris, Ellisville, MO), and 40 μm 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) added 30 min before stimulation. Neurons were depolarized for 20 min and quenched with 1 mm sodium kynurenate and 10 mm MgCl2. The neurons were immediately lysed in 2× boiling sample buffer, and proteins were separated by SDS-PAGE. Immunoblot analysis was performed with antibodies to phospho-CREB Ser133 (1:100), phospho-ERK (1:10,000), actin (1:5000), and CREB (1:200) to measure the level of phospho-CREB compared with total CREB.

Quantitative Image Analysis

Images were analyzed using Metamorph (Molecular Devices) and Igor Pro (Wavemetrics). For quantitation of punctate staining, puncta were counted in regions of interest in 2–4 tissue sections per condition from each of 3–4 experiments. In each experiment the number of puncta was normalized to the mean number of puncta counted in same-sized regions of interest from wild-type sections. Changes were compared by Student's t test as implemented in Excel (Microsoft, Redmond, WA). For analysis of nuclear fluorescence, whole nuclear regions of interest were taken from CREB and pCREB images, respectively, and mean pixel intensity was determined.

RESULTS

Interaction of AKAP15 with CaV1.2 Channels

AKAP15 targets PKA to an interaction site in the distal C terminus of L-type calcium channels in skeletal and cardiac muscle through LZ interactions (24, 37). The amino acid sequence of the AKAP binding domain in CaV1.1, CaV1.2, and CaV1.3 channels reveals high conservation of the hydrophobic LZ interaction motif (Fig. 1A), suggesting that AKAP15 may also target PKA to CaV1.2 and CaV1.3 channels in neurons. To examine if AKAP15 associates with CaV1.2 channels in brain, immunoprecipitation experiments were performed on solubilized extracts of adult mouse brain membranes prepared with either Triton X-100 or digitonin as detergent. These two detergents were selected because digitonin is a mild detergent that is unlikely to dissociate stable complexes, whereas Triton X-100 is more likely to disrupt hydrophobic interactions and separate loosely associated proteins. In both types of detergent extracts, a prominent protein band corresponding to AKAP15 was present in anti-CaV1.2 immunoprecipitates that were analyzed by SDS-PAGE and immunoblotting with anti-AKAP15 antibody (Fig. 1B). In contrast, no co-immunoprecipitation of AKAP15 was observed when nonimmune rabbit IgG was used in control immunoprecipitations under identical conditions (Fig. 1B). As previously reported (38), β2ARs were also specifically co-immunoprecipitated with CaV1.2 channels (Fig. 1B).

FIGURE 1.

FIGURE 1.

Co-immunoprecipitation of AKAP15 with CaV1.2 channels. A, amino acid sequence alignment of the LZ-like region identified in the distal C-terminal domain of CaV1.2 channels that interacts with AKAP15 in other members of the CaV1 family. B, proteins were immunoprecipitated (IP) from membrane extracts of adult mouse brain with an anti-CaV1.2 antibody (first lane) or control IgG (second lane) as indicated. Immunoblots were probed with anti-CaV1.2 (upper), anti-β2AR (middle), or anti-AKAP15 (lower). Positive control for immunoblotting was 40 μl of brain extract (third lane). TX-100, Triton X-100. C, immunoblots were stripped and reprobed with RII-biotin to reveal all AKAPs: anti-CaV1.2 (first lane), control IgG (second lane), 40 μl of brain extract (third lane), or secondary antibody alone (fourth lane). D, proteins were immunoprecipitated from E18 brain extracts with anti-CaV1.2 antibody (first lane) or control IgG (second lane) and brain lysate (third lane). Immunoblots were then probed with anti-CaV1.2 (upper), anti-β2AR (middle), and anti-AKAP15 (lower). E, proteins were immunoprecipitated from E18 brain extracts with anti-CaV1.2 (first lane) or control IgG (second lane) and AKAPs were detected using the RII-biotin assay. Brain lysate (40 μl) (third lane) served as a positive control, and secondary antibody alone (fourth lane) served as a negative control for the RII overlay.

To detect other AKAPs associated with specifically immunoprecipitated CaV1.2 channels, we re-probed immunoblots using the RII-biotin overlay assay to detect all AKAPs (25). As shown in Fig. 1C (first lane), three AKAPs with molecular masses corresponding to MAP2B (280 kDa), AKAP150 (150 kDa), and AKAP15 (15 kDa) were co-immunoprecipitated with CaV1.2 channels from brain membranes, but no co-immunoprecipitation was observed with non-immune IgG (Fig. 1C, second lane) or with secondary antibody alone (Fig. 1C, fourth lane). Although we observed Yotiao, another abundant neuronal AKAP, in our lysates, we did not find that it co-immunoprecipitated with CaV1.2 channels, further verifying the specificity of this interaction. These results confirm the identification of AKAP15 in these co-immunoprecipitates as well as β2ARs, MAP2B, and AKAP150 as reported previously (28, 39). We have previously found that AKAP15 binds directly to cardiac CaV1.2 channels via the C-terminal LZ motif (24), so it is likely that the co-immunoprecipitation observed here reflects direct interaction between these two proteins. On the other hand, it is possible that β2ARs, MAP2B, and AKAP150 are indirectly associated with CaV1.2 channels through intermediary proteins.

Co-immunoprecipitation of CaV1.2 Channels and AKAP15 from Embryonic Mouse Brain

Having established that AKAP15 associates with CaV1.2 channels in adult brain, we tested whether AKAP15 also associates with CaV1.2 channels earlier in development. Similar to adults, AKAP15 co-immunoprecipitated with CaV1.2 channels from embryonic day 18 (E18) brain with either Triton X-100 or digitonin as detergent (Fig. 1D). MAP2B, AKAP150, and the β2AR were also co-immunoprecipitated at this time point (Fig. 1, D and E), indicating that CaV1.2 channel/PKA signaling complexes are formed by E18. AKAP15 and the other associated proteins were not observed in immunoprecipitates obtained with control IgG (Fig. 1, D and E, second lanes), and there was no staining with secondary antibody alone in the RII-biotin overlay assay (Fig. 1E, fourth lane), confirming the specificity of immunoblotting.

Comparison of the average levels of co-immunoprecipitation of AKAP150, MAP2B, and AKAP15 detected in the RII-biotin overlay assay revealed that MAP2B and AKAP15 had similar levels of association with CaV1.2 channels in E18 mouse brain, whereas higher levels of AKAP15 were observed in association with CaV1.2 channels in adult brain than AKAP150 or MAP2B (supplemental Fig. 1, A–D).

Localization of CaV1.2 Channels, AKAP15, MAP2B, and β2ARs in Brain Neurons

Previous studies from our laboratory have established that AKAP15 and CaV1.2 channels are precisely co-localized in skeletal and cardiac myocytes (24, 26). L-type calcium currents have different functional roles in the dendrites and cell bodies of neurons; therefore, it is of interest to determine which subcellular compartments have CaV1.2 channels co-localized with AKAP15 and which classes of neurons contain this signaling complex. To determine the subcellular distribution of AKAP15 relative to neuronal CaV1.2 channels in vivo, we performed double-label immunocytochemistry on adult mouse brain slices using chicken anti-CaV1.2 and rabbit anti-AKAP15 antibodies. Sagittal tissue sections labeled with polyclonal antibodies against CaV1.2 channels (green, Fig. 2, B, E, and H) revealed staining concentrated in the soma and proximal dendrites, as expected from previous work (20, 21). AKAP15 showed a similar distribution (red, Fig. 2, A, D, and G). Overlapping localization of these proteins was evident in both dorsal cerebral cortex and the CA1/3 region of the hippocampus (yellow, Fig. 2, C, F, and I) when the images of their individual staining patterns were merged.

FIGURE 2.

FIGURE 2.

Localization of AKAP15 and CaV1.2 channels in cortical and hippocampal neurons. Sections of adult mouse brain were cut, fixed, and double-labeled with antibodies against CaV1.2 and AKAP15 as described under “Materials and Methods.” Representative examples of slices double-labeled with antibodies specific for AKAP15 or CaV1.2 channels are shown. A, D, and G, AKAP15, red. B, E, and H, CaV1.2, green. C, F, and I, merged images reveal double-labeled structures in yellow. A–F, dorsal cortex; G–I, hippocampal CA1 neurons. Scale bars = 20 μm.

MAP2B is a 280-kDa AKAP that was previously found to be associated with CaV1.2 channels (Ref. 28 and Fig. 1). To compare the localization of MAP2B and AKAP15, sagittal sections of adult mouse brain and cultured neurons were examined using double-labeling and confocal immunofluorescence microscopy. MAP2B was primarily localized to proximal and distal dendrites with little cell body staining (red, Fig. 3, B and E), whereas CaV1.2 channels were concentrated in the cell body and proximal dendrites (green, Fig. 3, A and D). Thus, the distributions of AKAP15 and MAP2B are partially complementary, with more MAP2B immunostaining in the distal dendrites and more AKAP15 in the cell bodies and proximal dendrites of these neurons (Fig. 3, C and F). In neurons cultured for 14 days in vitro, MAP2B was more strongly localized to dendrites (red, Fig. 3, H and K) compared with AKAP15, which showed stronger localization in the soma and proximal dendrites (blue, Fig. 3J). Quantification of AKAP15 localization showed that the ratio of AKAP15 staining intensity in the cell body is 3.5-fold greater than MAP2B (Fig. 3L). The partially complementary distribution of these two AKAPs suggests that they have distinct localizations and different functional roles in neurons.

FIGURE 3.

FIGURE 3.

Localization of CaV1.2 channels and MAP2B in cortical and hippocampal neurons. Sections of adult mouse brain were cut, fixed, and double-labeled with antibodies against CaV1.2 and MAP2B as described under “Materials and Methods.” A and D, CaV1.2, green. B and E, MAP2B, red. C and F, merged images. Regions of overlap are shown in yellow. A–C, dorsal cerebral cortex; D–F, CA3 hippocampus G, H, and I, cultured hippocampal neurons were fixed and double-labeled with anti-CaV1.2 (G) and anti-MAP2B (H). Regions of overlap are shown in yellow. J and K, representative examples of cultured hippocampal neurons that were fixed and double-labeled with anti-AKAP15 (J) and anti-MAP2B (K) are shown. L, quantification of localization of neuronal AKAPs in the cell body and dendritic regions are shown. Staining intensity of MAP2B and AKAP15 were quantified by determining mean pixel density for regions of interest in the dendrites and cell body. The ratios of the cell body pixel intensities to the dendritic pixel intensities were determined for each cell and antibody, and the ratios were averaged for each antibody. Asterisk, p < 0.01, Student's t-test. Scale bars = 40 μm.

Association of CaV1.3 Channels with AKAP15, MAP2B, and β2ARs

Alignment of the C-terminal domains of CaV1.2 and CaV1.3 channels (Fig. 1A) shows striking conservation of the amino acid sequence of CaV1.3 channels in the heptad repeat of hydrophobic residues that binds AKAP15 via a modified LZ. Sequence comparison of the adjacent regulatory domains in CaV1.3 channels, including the proximal C-terminal regulatory domain, the proteolytic cleavage site, and the distal C-terminal regulatory domain, also shows strongly conserved amino acid sequence at these sites (41). To examine the interactions between CaV1.3 channels and other members of the CaV1 channel signaling complex, we tested whether AKAP15, MAP2B, and β2AR are associated with CaV1.3 channels. Immunoprecipitation with a CaV1.3-specific antibody and subsequent immunoblotting for AKAP15 and the β2AR revealed that they both co-immunoprecipitated with CaV1.3 channels after both Triton X-100 solubilization (Fig. 4A, first lane) and digitonin solubilization (data not shown). Re-probing the immunoblots using the RII-biotin overlay assay revealed protein bands consistent in size with MAP2B and AKAP15 (Fig. 4B, first lane). No staining was observed with control nonimmune IgG (Fig. 4, A and B, second lanes) or with secondary antibody alone (Fig. 4B, fourth lane), confirming the specificity of antibody staining. Comparison of co-immunoprecipitation of AKAP15, AKAP150, and MAP2B in parallel experiments using the RII-biotin overlay assay revealed that they are associated with CaV1.2 and CaV1.3 channels at similar levels in adult mouse brain, with increased levels of AKAP15 compared with MAP2B and AKAP150 in both cases (supplemental Fig. 1D).

FIGURE 4.

FIGURE 4.

Coimmunoprecipitation and localization of CaV1.3 channels and AKAP15. A, isolated mouse brain membrane proteins were extracted with Triton X-100 (TX-100), and proteins were immunoprecipitated (IP) with anti-CaV1.3 antibody (first lane) or control IgG (second lane). Immunoblots were probed with anti-CaV1.3 (upper), anti-β2AR (middle), or anti-AKAP15 (lower). The positive control for immunoblotting was 40 μl of brain extract (third lane). B, immunoblots from panel A were stripped and reprobed with RII-biotin to reveal AKAPs co-immunoprecipitated with CaV1.3 channels (first lane). C–N, representative examples are shown of mouse brain slices double-labeled with antibodies specific for AKAP15 (green, panels C, F, I, and L), CaV1.3 (red, panels D, G, J, and M), and merged images (yellow, panels E, H, K, and N). C–H, dorsal cortex. I–K, hippocampal CA3. L–N, hippocampal CA1.

Localization of CaV1.3 Channels, AKAP15, MAP2B, and β2AR

Previous results have shown that CaV1.3 channels are located in cell bodies and proximal dendrites of hippocampal and cortical neurons (20). As the CaV1.3 channel comprises about 22% of neuronal CaV1 channels (20), we would expect CaV1.3 channels to only partially co-localize with AKAP15 and other members of the channel complex. We examined the distribution of CaV1.3 channels and AKAP15 using double immunostaining in mouse sagittal brain sections. Dense labeling of CaV1.3 channels was observed in cell bodies and proximal dendrites in all regions of the dorsal cerebral cortex and hippocampus (green, Fig. 4, C, F, I, and L), with similar staining patterns as AKAP15 (red, Fig. 4, D, G, J, and M). Regions of overlapping immunostaining are observed in yellow when images of their respective staining patterns are merged (yellow, Fig. 4, E, H, K, and N). Immunocytochemical studies showed that β2AR and CaV1.3 channels also have an overlapping distribution in cortical and hippocampal neurons (supplemental Fig. 2), as expected from our co-immunoprecipitation studies showing their specific interaction. In contrast to the localization of AKAP15, examination of MAP2B shows staining in proximal and distal dendrites in adult dorsal cortex (red, Fig. 5A) and CA1/CA3 regions (red, Fig. 5, D and G). Antibodies against CaV1.3 channels give a smooth pattern of staining in cell bodies and proximal dendrites (green, Fig. 5, B, E, and H). Merged images show primarily distinct localizations of MAP2B and CaV1.3 channels, except for small areas of overlap in the proximal dendrites and in some regions along the distal dendrites (yellow, Fig. 5, C, F, and I). Together with the images of Fig. 4, these results indicate that AKAP15 and MAP2B have complementary localizations, with MAP2B more concentrated in distal dendrites and AKAP15 more concentrated in cell bodies and proximal dendrites. The localization of CaV1.3 channels overlaps more completely with AKAP15 (Fig. 4) than with MAP2B (Fig. 5). Therefore, our results suggest that CaV1.3 channels form complexes with AKAP15 in their cell bodies and proximal dendrites as well as less extensive complexes with MAP2B in their distal dendrites. These localizations may differ in neurons in other regions of the brain.

FIGURE 5.

FIGURE 5.

Localization of MAP2B and CaV1.3 channels in cortical and hippocampal neurons. Sections of adult mouse brain were cut, fixed, and double-labeled with antibodies against CaV1.3 and MAP2B as described under “Materials and Methods.” Representative examples of slices double-labeled with antibodies specific for CaV1.3 channels and MAP2B are illustrated. A–C, dorsal cerebral cortex; D–F, hippocampal CA3 region; G–I, hippocampal CA1 region. A, D, and G, Map2B, red; B, E, and H, CaV1.3, green; C, D, and I, merged images. Areas of overlap are yellow. Scale bars are 50 μm.

Disruption of the Distal C Terminus of CaV1.2 Channels

Similar to the α1 subunit of skeletal muscle CaV1.1 channels, the CaV1.2 channel exists in two size forms, a full-length form and a distal C-terminal truncated form resulting from posttranslational proteolytic processing in vivo (20, 31). AKAP15 binds to the distal C terminus and is required for regulation of CaV1.2 channels in cardiac myocytes by PKA (24, 37). These studies of cardiac myocytes imply that the C terminus exerts an inhibitory effect on L-type calcium currents conducted by CaV1 channels, but the effects of C-terminal truncation have not been investigated in neurons. To examine the effects of C-terminal truncation in vivo, we generated a targeted knock-in mouse line with a stop codon that deletes the distal C terminus from the protein at Gly-1796 (CaV1.2ΔDCT (33)). Although the CaV1.2ΔDCT heterozygous mutant mice show development, lifespan, and gross phenotype that are similar to their wild-type littermates, matings of heterozygotes consistently failed to generate viable homozygous mutant offspring when the genotypes were analyzed upon weaning. Approximately Mendelian ratios of the three genotypes were obtained in 7 litters recovered at E16–18: 16 wild types, 25 heterozygotes, and 15 homozygotes. The homozygous mutant pups were indistinguishable from the wild-type littermates at E16–18, but they die perinatally from vascular dysfunction, which also leads to dilated cardiac myopathy and heart failure (33).

When probed with the anti-CaV1.2 antibody that recognizes an epitope in the intracellular loop connecting domains II and III, membranes from E18 wild-type and CaV1.2ΔDCT mice had similar amounts of CaV1.2 channels (Fig. 6A, top). In contrast, immunoblots using an antibody against the truncated distal C terminus detect CaV1.2 channels in wild-type but not in homozygous CaV1.2ΔDCT mice, confirming successful truncation of distal C-terminal domain in CaV1.2 channels (Fig. 6A, middle). There was no apparent up-regulation of CaV1.3 channels in homozygous mutant mice (Fig. 6A, bottom). Neurons dissociated from CaV1.2ΔDCT homozygotes at E18 (Fig. 6B) thrived in subsequent cell culture and could be studied by immunocytochemical, physiological, and biochemical methods.

FIGURE 6.

FIGURE 6.

Generation of CaV1.2ΔDCT mice. A, brain calcium channel expression in CaV1.2ΔDCT mice. Brain membrane proteins (100 μg) from wild-type and homozygous mice at E18 were analyzed by SDS-PAGE and immunoblotting. Top, anti-CaV1.2 against the intracellular loop between domains I and II of CaV1.2 channels is shown. Middle, anti-CH2 against the distal C-terminal tail of CaV1.2 is shown. Bottom, anti-CaV1.3. B, a representative bright-field view of a hippocampal pyramidal neuron dissociated from E18 mice. The pyramidal neurons were identified by bulbous, triangular cell bodies with prominent proximal dendritic extensions. Scale bar = 25 μm.

Localization of CaV1 Channels in Neurons of CaV1.2ΔDCT Mice

As in neurons in adult hippocampus and cerebral cortex, CaV1.2 channels were localized to the cell bodies and proximal dendrites of cultured wild-type (Fig. 7, A and B) and CaV1.2ΔDCT (Fig. 7, C and D) hippocampal neurons. Similarly, CaV1.3 channels were localized in higher density in the cell bodies of cultured neurons from both wild-type (Fig. 7, E and F) and CaV1.2ΔDCT (Fig. 7, G and H) mice. Anti-CH2 antibody, recognizing the CaV1.2 distal C terminus, stained wild-type (Fig. 7, I and J) but not CaV1.2ΔDCT neurons (Fig. 7, K and L). Examination of the localization of calcium channels in brain slices from the developing cerebral cortex of E18 mice by immunocytochemistry and confocal microscopy revealed similar staining of the cell surface of neurons for wild-type (Fig. 7M) and CaV1.2ΔDCT mice (Fig. 7P), and no apparent compensatory changes in localization of CaV1.3 channels were evident (Fig. 7, N and Q). CaV1.2ΔDCT animals lack immunostaining with antibodies against the CaV1.2 distal C terminus as expected (Fig. 7R).

FIGURE 7.

FIGURE 7.

Localization of CaV1 channel complexes in the dorsal cortex of CaV1.2ΔDCT mice. A–D, CaV1.2 staining along the cell body and dendrites of cultured hippocampal neurons from wild-type (A and B) and CaV1.2ΔDCT mice (C and D). E–H, CaV1.3 staining of cultured hippocampal neurons from wild-type (E and F) and CaV1.2ΔDCT mice (G and H). I–K, cultured hippocampal neurons stained with anti-CH2 recognizing the distal C terminus of CaV1.2. I and J, wild-type hippocampal neurons. K, CaV1.2ΔDCT neuron. L, same neuron as I is viewed using transmitted light and Nomarski optics. M and O, wild-type mouse brain slices stained with anti-CaV1.2 (M) anti-CaV1.3 (N) or anti-CH2 (O). P and R, CaV1.2ΔDCT mouse brain slices stained with anti-CaV1.2 (P) anti-CaV1.3 (Q) or anti-CH2 (R). Scale bars = 40 μm.

Localization of AKAP15 in Neurons of CaV1.2ΔDCT Mice

In skeletal and cardiac myocytes, CaV1.2 channels bind AKAP15 at a specific site in the distal C-terminal domain, beyond the point of truncation of CaV1.2ΔDCT (24, 37). To test whether AKAP15 interacts with CaV1.2 channels via the distal C terminus in vivo, CaV1.2 channels in brain membrane lysates of E18 wild-type or CaV1.2ΔDCT mice were immunoprecipitated with an anti-CaV1.2 antibody or control IgG and analyzed by SDS-PAGE and immunoblotting for association of CaV1.2 with AKAP15 and β2ARs (Fig. 8, A and B). Immunoblotting revealed an AKAP15 band at an apparent molecular mass of 15 kDa co-immunoprecipitated with CaV1.2 channels from wild-type mice, but this protein band was completely absent from CaV1.2ΔDCT mice (Fig. 8, A and B, second lanes). In contrast, co-immunoprecipitation of the β2AR was not reduced by deletion of the distal C terminus, supporting the idea it does not bind primarily to the distal C-terminal region of CaV1.2 channels (Fig. 8, A and B, second lanes).

FIGURE 8.

FIGURE 8.

Association of AKAP15 with the distal C terminus of CaV1.2 channels in wild-type and CaV1.2ΔDCT mice. A and B, calcium channels from wild-type (A) and CaV1.2ΔDCT (B) mice were solubilized, and calcium channel complexes were immunoprecipitated with antibodies against CaV1.2 channels. Immunoprecipitates (IP) and lysate (Lys) were analyzed by SDS-PAGE and immunoblotting with antibodies against CaV1.2, AKAP15, and β2AR. Brain membrane lysate, enriched by affinity chromatography on a wheat germ agglutinin column (WGA) was used as a positive control for immunoblotting. C and D, immunolocalization of AKAP15 in slices of the dorsal cerebral cortex from wild-type (C) and CaV1.2ΔDCT (D) mice. Scale bar = 40 μm. E, quantification of anti-AKAP15 puncta in wild-type and CaV1.2ΔDCT mice is shown. The number of puncta was counted in regions of interest of equal size in each section. Counts for CaV1.2ΔDCT sections were normalized to the mean of the wild-type sections for each experiment and each antibody. The mean normalized counts are plotted. CaV1.2, n = 3 experiments; AKAP15, n = 4 experiments. 2–4 slices were counted per experiment. Asterisk, p < 0.01, Student's t test.

Deletion of the distal C-terminal domain of CaV1.2 channels would be expected to alter the co-localization of the bound AKAP15 with CaV1.2 channels in CaV1.2ΔDCT mice. Sections of developing cerebral cortex at E18 were examined for AKAP15 immunostaining, and these images revealed a significant change in distribution of AKAP15 on the cell surface from a punctate pattern to a smoother pattern in CaV1.2ΔDCT mice (Fig. 8, C and D). Quantification of AKAP15 puncta revealed a 53 ± 0.1% reduction in CaV1.2ΔDCT mice (Fig. 8E, n = 4 experiments, p < 0.01). These results show that AKAP15 localization is dependent on the intact distal C terminus of CaV1.2 channels and suggest that AKAP15 can no longer bind to the distal C-terminal domain of CaV1.2 channels in punctate clusters because its binding site has been deleted.

Functional Properties of Calcium Channels in CaV1.2ΔDCT Neurons

When expressed in heterologous cells such as Xenopus oocytes and human embryonic kidney cells, truncated CaV1.2 channels are more active than wild type (4244). To examine the physiological significance of the distal C terminus in the function and regulation of CaV1.2 channels in vivo, we dissociated neurons from mouse hippocampus at E18 and measured whole-cell L-type barium currents through CaV1 channels in wild-type and CaV1.2ΔDCT neurons. Hippocampal pyramidal cells were identified by their bulbous, triangular cell bodies with prominent proximal dendritic extensions (Fig. 6B). After establishing the whole-cell patch clamp configuration and recording stable currents in 5 mm Ba2+, we inhibited L-type barium currents by perfusing the L-type calcium channel blocker nimodipine (10 μm) (Fig. 9A). We calculated nimodipine-sensitive L-type barium current by subtracting the barium current in the presence of nimodipine from total current. Contrary to our expectations from experiments with transfected cells, there was a substantial decrease in the L-type barium current in neurons from heterozygous and homozygous CaV1.2ΔDCT neurons (Fig. 9B). Wild-type, heterozygous, and homozygous CaV1.2ΔDCT pyramidal neurons conducted similar non-L-type barium currents (Fig. 9C). Despite the large change in current amplitude, no significant changes in the voltage dependence of activation of L-type barium currents were observed across the three genotypes (Fig. 9B). These results reveal a previously unrecognized requirement for the distal C-terminal domain in maintaining normal functional expression of CaV1.2 channels in neurons in vivo.

FIGURE 9.

FIGURE 9.

Effects of C-terminal truncation on the functional properties of CaV1.2 channels in cultured hippocampal neurons. Inward barium currents (IBa) were recorded from CA1/3 hippocampal pyramidal cells cultured for 8–14 days from wild-type, heterozygous, or homozygous CaV1.2ΔDCT mice. A, representative families of barium currents evoked by depolarizations ranging from −60 to 100 mV in 10-mV steps from a holding potential of −70 mV under control conditions (top), and after perfusion of 10 μm nimodipine (bottom). B, mean current-voltage curves for nimodipine-sensitive barium current (L-type) are shown. HET, heterozygous; HOM, homozygous. C, mean current-voltage curves are shown for barium current after subtraction of traces recorded in the presence of 10 μm nimodipine to yield nimodipine-insensitive barium current.

Regulation of CREB Phosphorylation in Neurons from CaV1.2ΔDCT Mice

It is well established that gene expression and new protein synthesis are required for long-lasting changes of synaptic strength, but it is not known what signaling mechanisms transmit information from the membrane to the nucleus to support gene expression. The transcription factor CREB has been shown to drive the expression of a number of genes that regulate neuronal survival and plasticity, and phosphorylation of CREB on Ser133 is thought to be an important process underlying long-term memory (913, 4547). Calcium entering through neuronal CaV1 channels has a privileged role in signaling to activation of CREB phosphorylation (7, 8). Moreover, experiments in cultured neurons suggest that the C-terminal domain of the L-type calcium channel directly regulates CREB phosphorylation in the nucleus (8).

To determine whether the distal C-terminal domain of CaV1.2 channels containing the AKAP15 interaction site is required for activation of CREB phosphorylation, we cultured hippocampal neurons from E18 wild-type and CaV1.2ΔDCT mice for 10–14 days in vitro. We depolarized these neurons with 65 mm KCl after blocking N-methyl-d-aspartate receptors with d,l,-2-amino-5-phosphonovaleric acid, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors with 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and sodium channels with tetrodotoxin, and we measured CREB Ser133 phosphorylation in response to depolarization and calcium entry. Neurons were lysed in boiling sample buffer, proteins were separated by SDS-PAGE, and the level of phospho-CREB was measured and compared with total CREB by immunoblotting with normalization to actin controls (Fig. 10, A–D). As a positive control treatment, we tested the effect of brain-derived neurotrophic factor, which increases both CREB and ERK phosphorylation (48, 49). As expected, brain-derived neurotrophic factor increased both phospho-CREB and phospho-ERK in wild-type animals (Fig. 10A). Quantification of the results for brain-derived neurotrophic factor stimulation of phospho-CREB showed that it was increased by 2.23 ± 0.27-fold (Fig. 10E). Stimulation with 65 mm KCl also gave a substantial increase of both phospho-CREB (Fig. 10, A and E) and phospho-ERK (Fig. 10C). Quantification of these results revealed that KCl stimulation increased pCREB by 1.96 ± 0.17-fold in hippocampal cultures from wild-type mice (p < 0.001, Fig. 10E), but this effect was reduced to 1.45 ± 0.14 (p < 0.02) in heterozygous CaV1.2ΔDCT mice and was reduced to the unstimulated base line in homozygous CaV1.2ΔDCT mice (1.14 ± 0.10, p > 0.2, Fig. 10E).

FIGURE 10.

FIGURE 10.

Excitation-transcription coupling in CaV1.2ΔDCT neurons. CA1/3 hippocampal pyramidal cells were cultured for 8–14 days from wild-type, heterozygous, or homozygous CaV1.2ΔDCT mice. A–E, wild-type hippocampal neurons were unstimulated with sham media additions (U and Uns) or stimulated with brain-derived neurotrophic factor (BDNF). Hippocampal neurons from wild-type (WT), heterozygous (HET), or homozygous (HOM) CaV1.2ΔDCT mice were stimulated by depolarization with 65 mm KCl. Samples were lysed in boiling sample buffer, separated by SDS-PAGE, and immunoblotted for phospho-CREB. A, phospho-CREB. B, total CREB. C, phospho-Erk. D, actin. E, CREB phosphorylation (phospho-CREB/total CREB) normalized to unstimulated cells from experiments analogous to panel A (±S.E., n = 8) is shown. F–K, CA1/3 hippocampal pyramidal cells from wild-type or CaV1.2ΔDCT mice were cultured for 8–14 days. Hippocampal neurons were either unstimulated with a sham medium change or stimulated by depolarization with 65 mm KCl, fixed, and labeled with either total CREB or phospho-CREB antibodies. F, WT, pCREB, unstimulated. G, WT, pCREB, stimulated with 65 mm KCl. H, WT, total CREB. I, CaV1.2ΔDCT, pCREB, unstimulated. J, CaV1.2ΔDCT, stimulated with 65 mm KCl. K, CaV1.2ΔDCT, total CREB. Scale bars = 40 μm. L, quantification of nuclear staining by phospho-CREB in sham-stimulated and KCl-depolarized cells (left) or for total CREB (right). Nuclear regions of interest were selected, and mean pixel intensity measured.

Finally, we examined whether KCl-stimulated depolarization of CaV1 channels would reveal similar loss of excitation-phosphorylation coupling using confocal microscopy with antibodies against CREB and pCREB. KCl depolarization increased phosphorylation of CREB in the nucleus of wild-type neurons (Fig. 10, G and L) but not in CaV1.2ΔDCT neurons (Fig. 10, J and L). Unstimulated phosphorylation of CREB in the nucleus appears similar in both wild-type and CaV1.2cΔDCT neurons (Fig. 10, F, I, and L), and total CREB does not appear to change (Fig. 10, H, K, and L). These results confirm our conclusions as seen in our immunoblotting experiments that neurons from CaV1.2ΔDCT mice have impaired coupling of depolarization to phosphorylation of CREB.

DISCUSSION

Our results reveal three previously unrecognized functional roles for the distal C-terminal domain in the signaling complexes formed by CaV1 channels and AKAPs. First, in contrast to previous studies (28), the distal C-terminal domain of CaV1.2 channels binds AKAP15 and alters its localization in neurons in vivo. CaV1.3 channels also form a signaling complex with AKAP15 in brain neurons. Second, against expectations from previous studies in transfected cells (4244), the distal C-terminal domain is required for normal levels of functional expression of CaV1.2 channels in neurons in vivo. Finally, in contrast to expectations from previous work showing that binding of calmodulin to the IQ-like motif in the proximal C-terminal domain is required for excitation-transcription coupling (8), we find the distal C-terminal domain of CaV1.2 channels is also required for normal coupling of excitation to phosphorylation of the transcription factor CREB. These three functions of the distal C-terminal domain in the CaV1/AKAP signaling complex in neurons are considered in more detail below.

CaV1.2 Channels Bind AKAP15 in Brain Neurons

Regulation of CaV1 channels in skeletal and cardiac myocytes by the β-adrenergic signaling pathway requires PKA anchored to the distal C-terminal domain by AKAP15 (24, 26, 37). Previously, CaV1.2 channels in neurons were found to interact with the AKAP MAP2B but not with AKAP15 (28). Our results with two different methods of detergent extraction of CaV1.2 channels show that CaV1.2 channels are co-immunoprecipitated with AKAP15 and are specifically associated with it. β2ARs and MAP2B are also associated with CaV1.2 channels in our co-immunoprecipitation experiments, as expected from previous work (28). These associations are specific because these two neuronal AKAPs, but neither mAKAP nor Yotiao, two other abundant neuronal AKAPs, were detected in our RII-biotin overlay assays. Although all of these proteins are associated with CaV1.2 channels, our experiments do not determine whether these associations are direct or what fraction of individual CaV1.2 channels is associated with these kinase anchoring proteins.

CaV1.3 Channels Form a Signaling Complex with AKAP15 in Brain Neurons

Our results provide the first evidence that AKAP15, MAP2B, and β2ARs associate with CaV1.3 channels. The high level of amino acid sequence conservation in the C-terminal region of CaV1.2 and CaV1.3 channels suggests that both of these channels bind AKAP15 and are proteolytically processed in vivo. Based on our results with CaV1.2 channels (42) and the high level of conservation of amino acid sequence at the putative cleavage site in the C-terminal domain (41), it is likely that the proteolytically processed distal C-terminal domain of CaV1.3 remains associated with the channels through noncovalent interactions with the proximal C-terminal domain and serves as a regulator of channel function.

Overlapping Localization of CaV1.2 and CaV1.3 Channels with AKAP15

Previous studies have shown that AKAP15 and CaV1.2 channels closely co-localize in transverse tubule-sarcoplasmic reticulum junctions in skeletal and cardiac muscle (24, 26), but co-localization of CaV1.2 and CaV1.3 channels with AKAP15, MAP2B, or β2ARs has not been studied in neurons. Double-label immunocytochemical studies revealed that AKAP15 has an overlapping localization in vivo with CaV1.2 and CaV1.3 channels in brain neurons in the cell soma as well as the proximal dendrites and is closely co-localized in punctate clusters of CaV1.2 channels. These results indicate that a substantial fraction of CaV1 channels in the brain have overlapping localization with AKAP15.

In contrast, MAP2B is primarily expressed in distal dendrites and is less extensively co-localized with CaV1.2 and CaV1.3 channels in proximal dendrites and in small areas on distal dendrites. MAP2B and AKAP15 have complementary localizations, with AKAP15 present at higher density in cell bodies and proximal dendrites and MAP2B present at higher density in more distal dendritic regions with little somatic staining. These results suggest that these two AKAPs may have complementary roles in localizing PKA in different cellular compartments and that MAP2B may have a more limited role in the regulation of the CaV1 channels. Assembly of a β2AR·CaV1.2 complex may locally restrict signaling from the receptor to the channel (38), and our results show that β2ARs interact with both CaV1.2 and CaV1.3 channels, supporting a role for highly localized regulation of activity of both channels by β2ARs.

The Distal C-terminal Domain Is Required for Punctate Localization of AKAP15

If CaV1.2 channels are a major binding partner of AKAP15, deletion of the distal C-terminal domain with its AKAP15 binding site should prevent the interaction of AKAP15 with CaV1.2 channels and alter the punctate localization of AKAP15. Using CaV1.2ΔDCT mice lacking the distal C terminus, we found that AKAP15 does not co-immunoprecipitate with brain CaV1.2 channels, in contrast to our results with wild-type littermates. In addition, we observed a substantial change in distribution of AKAP15 from punctate staining to smooth cell surface distribution. These results support the idea that AKAP15 is targeted to the membrane with its lipid anchor but can no longer localize to CaV1.2 channels because the binding site is unavailable. Evidently, AKAP15 binding to the distal C terminus of CaV1.2 channels is a major determinant of AKAP15 localization in vivo.

The Distal C-terminal Domain Is Required for Normal Functional Expression of CaV1.2 Channels in Neurons in Vivo

C-terminal truncation of the CaV1.2 channel results in a 4–6-fold higher calcium channel activity than the full-length form in heterologous expression systems (42, 43), and the co-expressed distal C terminus is a potent inhibitor of channel activity (42, 50). These studies imply that the C terminus exerts an inhibitory effect on calcium current, but these effects of C-terminal truncation have not been determined in vivo. In contrast to these expectations from in vitro studies, we found that whole-cell L-type calcium currents were diminished in heterozygous and homozygous CaV1.2ΔDCT hippocampal neurons. Approximately 30% of the L-type current was lost in heterozygous (HET) CaV1.2ΔDCT neurons and ∼50% in homozygous (HOM) CaV1.2ΔDCT neurons (normalized mean current values: WT, 1.0 ± 0.1; HET, 0.70 ± 0.14; HOM, 0.47 ± 0.08). Inhibition of PKA does not affect basal L-type currents (e.g. 51), indicating that reduction of channel activity rather than reduction of basal phosphorylation by PKA is likely to be responsible for this effect. This nearly linear loss of calcium channels in neurons suggests there is no compensatory increase of other CaV1 channels that contributes to L-type calcium currents in the homozygous CaV1.2ΔDCT mice. These results show that the distal C-terminal is required for normal functional expression of CaV1.2 channels in neurons in vivo.

Studies of CaV1.2 channels in cardiac myocytes dissociated from the hearts of these E18 CaV1.2ΔDCT mice reveal an even greater loss of CaV1.2 channel protein and CaV1.2 current (33). Those results suggest a general requirement for the distal C terminus and/or for its proteolytic processing in the functional expression of CaV1.2 channels in cardiac myocytes.

The Distal C-terminal Domain Is Required for Excitation-Transcription Coupling

Changes in L-type calcium currents lead to sustained activation of CREB through phosphorylation of Ser133. Although L-type calcium currents comprise only 15–20% of the total calcium current in most central neurons, they have a predominant role in regulation of CREB phosphorylation and subsequent gene expression (6, 8, 53). Our experiments with cultured neurons from CaV1.2ΔDCT mice show that the distal C-terminal domain of the CaV1.2 channels is required for normal regulation of CREB phosphorylation in the nucleus, as CaV1.2ΔDCT neurons have a nearly complete loss of stimulation of CREB phosphorylation. These results indicate that the distal C-terminal domain of CaV1.2 channels is critically involved in excitation-transcription coupling in vivo.

CaV1.2 channels also bind AKAP79/150 via LZ interactions with the distal C-terminal domain (54). Interaction of CaV1.2 channels with the phosphoprotein phosphatase calcineurin through its binding to AKAP79/150 enhances calcium-dependent gene regulation by the nuclear factor of activated T cells (NFAT) and also reduces peak L-type calcium current-conducted CaV1.2 channels, perhaps as a form of negative feedback regulation of channel activity (54). These results support a key role for the distal C-terminal domain in regulation of gene expression by the NFAT pathway in addition to the CREB pathway.

Recent work suggests that the distal C-terminal domain may serve as a regulator of neuronal gene transcription itself in brain neurons (40). Immunocytochemical and fluorescent-tagging studies detected the distal C-terminal domain in the nuclei of cultured embryonic neurons and a small population of neurons in vivo. Transfection of the distal C-terminal domain resulted in nuclear localization and in activation of gene transcription. Our experiments provide further support for this model by showing that the distal C-terminal domain is required for normal activation of CREB in vivo. It will be interesting in future studies to determine whether this mechanism plays a pivotal role in long term synaptic plasticity via regulation of gene transcription.

Three Functional Roles for the Signaling Complex Formed by the Distal C terminus of CaV1.2 Channels in Brain Neurons

Overall, our results point to three previously unrecognized functional roles of the signaling complex formed by distal C-terminal domain of CaV1 channels in neurons. The distal C terminus binds AKAP15 and localizes it in punctate clusters with the CaV1.2 channel itself. The distal C-terminal domain of CaV1.3 channels has the same function. The distal C-terminal domain is required for normal functional expression of CaV1.2 channels in brain neurons in vivo. The mechanism of this effect may involve altered processing, assembly, and cell surface expression. Finally, the distal C-terminal domain is required for coupling of excitation to phosphorylation of the transcription factor CREB, which may regulate transcription of numerous genes in neurons including the gene encoding CaV1.2 channels, which is regulated in cardiac myocytes (52). These results establish the distal C terminus as a signaling hub for calcium-dependent regulation of cell function in brain neurons in vivo.

Acknowledgments

We thank Dr. Joanne Hulme and Dr. Charles Yokoyama for expert technical assistance and helpful discussions. Additionally, we thank Dr. Marc Grün and Dr. Detlef Hof for help with statistical analysis.

*

This work was supported, in whole or in part, by National Institutes of Health Grant Training Grants T32 GM07750 (to M. R. M.) and T3207332 (to J. P. C.) and Research Grants P01 HL44948, R01 HL85372, and R01 NS22625 (to W. A. C.).

Inline graphic

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.

3
The abbreviations used are:
CREB
cAMP response element-binding protein
LZ
leucine zipper
HBSS
Hanks' balanced salt solution
AKAP15
A-kinase anchoring protein 15
MAP2B
microtubule-associated protein 2B
SM
skim milk
β2AR
β2-adrenergic receptor.

REFERENCES


Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES